Hologic Net Common Equity Issued/Repurchased 2010-2024 | HOLX
Hologic annual/quarterly net common equity issued/repurchased history and growth rate from 2010 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
- Hologic net common equity issued/repurchased for the quarter ending December 31, 2024 was $-0.505B, a 24.31% decline year-over-year.
- Hologic net common equity issued/repurchased for the twelve months ending December 31, 2024 was $-2.730B, a 85.62% increase year-over-year.
- Hologic annual net common equity issued/repurchased for 2024 was $-0.815B, a 78.74% increase from 2023.
- Hologic annual net common equity issued/repurchased for 2023 was $-0.456B, a 14.24% decline from 2022.
- Hologic annual net common equity issued/repurchased for 2022 was $-0.532B, a 30.91% increase from 2021.
| Hologic Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $-815 |
| 2023 | $-456 |
| 2022 | $-532 |
| 2021 | $-406 |
| 2020 | $-602 |
| 2019 | $-163 |
| 2018 | $-259 |
| 2017 | $-220 |
| 2016 | $-266 |
| 2015 | $57 |
| 2014 | $72 |
| 2013 | $63 |
| 2012 | $29 |
| 2011 | $25 |
| 2010 | $13 |
| 2009 | $11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $12.153B | $4.030B |
| Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. | |||